1	Dimethyldithiocarbamate	Dimethyldithiocarbamate	_	_	_	_	_	_	_
2	inhibits	inhibit	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	vitro	vitro	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	primary	primary	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	CD4+	cd4+	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Dithiocarbamates	Dithiocarbamate	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	DTC	DTC	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	diverse	diverse	_	_	_	_	_	_	_
8	group	group	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	industrial	industrial	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	therapeutic	therapeutic	_	_	_	_	_	_	_
13	chemicals	chemical	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	have	have	_	_	_	_	_	_	_
16	been	be	_	_	_	_	_	_	_
17	reported	report	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	inhibit	inhibit	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	enhance	enhance	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	have	have	_	_	_	_	_	_	_
24	no	no	_	_	_	_	_	_	_
25	effect	effect	_	_	_	_	_	_	_
26	on	on	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	immune	immune	_	_	_	_	_	_	_
29	system	system	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	apparent	apparent	_	_	_	_	_	_	_
3	inconsistencies	inconsistency	_	_	_	_	_	_	_
4	reflect	reflect	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	complexity	complexity	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	DTCs	DTC	_	_	_	_	_	_	_
10	biological	biological	_	_	_	_	_	_	_
11	activities	activity	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	are	be	_	_	_	_	_	_	_
14	probably	probably	_	_	_	_	_	_	_
15	due	due	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	part	part	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	differences	difference	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	dose	dose	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	route	route	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	exposure	exposure	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	animal	animal	_	_	_	_	_	_	_
28	species	specie	_	_	_	_	_	_	_
29	used	use	_	_	_	_	_	_	_
30	and/or	and/or	_	_	_	_	_	_	_
31	specific	specific	_	_	_	_	_	_	_
32	compound	compound	_	_	_	_	_	_	_
33	tested	test	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	described	describe	_	_	_	_	_	_	_
4	herein	herein	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	undertaken	undertake	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	investigate	investigate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	immunotoxicity	immunotoxicity	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	one	one	_	_	_	_	_	_	_
13	member	member	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	this	this	_	_	_	_	_	_	_
16	family	family	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	dimethyldithiocarbamate	dimethyldithiocarbamate	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	DMDTC	DMDTC	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	demonstrate	demonstrate	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	0.1-0.5	0.1-0.5	_	_	_	_	_	_	_
5	microM	microM	_	_	_	_	_	_	_
6	DMDTC	DMDTC	_	_	_	_	_	_	_
7	inhibits	inhibit	_	_	_	_	_	_	_
8	TNF-alpha-induced	tnf-alpha-induced	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	primary	primary	_	_	_	_	_	_	_
14	human	human	_	_	_	_	_	_	_
15	CD4+	cd4+	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	accompanied	accompany	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	loss	loss	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	viability	viability	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	DMDTC-treated	dmdtc-treated	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	retain	retain	_	_	_	_	_	_	_
17	other	other	_	_	_	_	_	_	_
18	active	active	_	_	_	_	_	_	_
19	signaling	signaling	_	_	_	_	_	_	_
20	pathways	pathway	_	_	_	_	_	_	_
21	throughout	throughout	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	exposure	exposure	_	_	_	_	_	_	_
24	duration	duration	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	apparently	apparently	_	_	_	_	_	_	_
7	permanent	permanent	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	DMDTC-treated	dmdtc-treated	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	did	do	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	regain	regain	_	_	_	_	_	_	_
15	normal	normal	_	_	_	_	_	_	_
16	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	even	even	_	_	_	_	_	_	_
20	after	after	_	_	_	_	_	_	_
21	72	72	_	_	_	_	_	_	_
22	h	h	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	culture	culture	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	DMDTC	DMDTC	_	_	_	_	_	_	_
2	does	do	_	_	_	_	_	_	_
3	not	not	_	_	_	_	_	_	_
4	appear	appear	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	alter	alter	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	directly	directly	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	pre-incubation	pre-incubation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	extracts	extract	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	DMDTC	DMDTC	_	_	_	_	_	_	_
16	does	do	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	diminish	diminish	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	this	this	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	further	further	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	0.1-0.5	0.1-0.5	_	_	_	_	_	_	_
6	microM	microM	_	_	_	_	_	_	_
7	DMDTC	DMDTC	_	_	_	_	_	_	_
8	inhibits	inhibit	_	_	_	_	_	_	_
9	intracellular	intracellular	_	_	_	_	_	_	_
10	IL-2	il-2	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	decreases	decrease	_	_	_	_	_	_	_
14	surface	surface	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	CD25	cd25	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	alpha	alpha	_	_	_	_	_	_	_
21	subunit	subunit	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	IL-2	il-2	_	_	_	_	_	_	_
25	receptor	receptor	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	T	t	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	stimulated	stimulate	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	phorbol	phorbol	_	_	_	_	_	_	_
33	ester	ester	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	DMDTC	DMDTC	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	potent	potent	_	_	_	_	_	_	_
9	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
10	compound	compound	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	vitro	vitro	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

